** Medical gloves and surgical gowns maker Ansell ANN.AX falls 1.3% to A$29.33
** Morgan Stanley factors in downside risk due to U.S. tariffs, despite ANN expecting to offset impacts through pricing
** Lowers PT to A$33.40 from A$37.20; retains 'equal-weight'
** Trims revenue growth for co's Industrial and Healthcare units, citing volume risk given slowing macroeconomic growth
** Cuts EPS forecast by 9% in FY26 and 11% in FY27; both below Visible Alpha consensus
** YTD, ANN down ~13%
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.